Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Velpharma ApS
APS
Active
CVR 43655701
Frederikssundsvej 68B, 1. mf
Computer programming activities · NACE 6210
Est. 2022
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -42K
+268% vs 2023
EBITDA margin
100.0%
-268% vs 2023
Equity ratio
-30.0%
Financial strength
Net profit 2024
DKK -42K
-268% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -42K
+268%
EBITDA
DKK -42K
-268%
Net profit
DKK -42K
-268%
Total assets
DKK 43K
-49%
Equity
DKK -13K
-145%
Employees
—
—
Company information
Legal name
Velpharma ApS
CVR number
43655701
Legal form
Anpartsselskab
NACE code
6210 · Computer programming activities
Founded
21. november 2022
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af 1 direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Frederikssundsvej 68B, 1. mf
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computer programming activities
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
-11
-42
Staff expenses
-0
-0
EBITDA
-11
-42
Depreciation & amort.
-0
-0
EBIT
-11
-42
Net financials
0
0
Profit before tax
-11
-42
Tax
-0
-0
Net profit
-11
-42
Balance sheet
DKK thousands
Item
2023
2024
Total assets
85
43
Equity
29
-13
Long-term debt
0
0
Short-term debt
56
56
Total debt
56
56
Financial ratios
5-year trend
EBITDA margin
-4160000.0%
This company
15.8%
Market median
-26329214% vs market
2023
2024
Equity ratio
-30.0%
This company
38.2%
Market median
-179% vs market
2023
2024
Return on equity
-4160000.0%
This company
18.4%
Market median
-22608796% vs market
2023
2024
Net profit margin
-4160000.0%
This company
8.1%
Market median
-51358125% vs market
2023
2024
Asset turnover
-0.97×
This company
1.12×
Market median
-187% vs market
2023
2024
Debt / equity
4.33×
This company
0.62×
Market median
-598% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-11-21 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (4)
MB
Mikkel Bloch Lauritzen
Management
Management
2022
JK
Jannik Khirkhoff Jonsson
Management
Management
2022
RB
Rasmus Blaabjerg Ahm Sørensen
Chief Executive Officer
Chief Executive Officer
2022
JB
Jacob Benné Arleth
Management
Management
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Velpharma Holding ApS
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Velpharma Holding ApS
Velpharma ApS
(this company)
Board network connections
Board members of Velpharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mikkel Bloch Lauritzen
Management
0 companies
Jannik Khirkhoff Jonsson
Management
0 companies
Rasmus Blaabjerg Ahm Sørensen
Chief Executive Officer
0 companies
Jacob Benné Arleth
Management
0 companies